| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,624 |
11,844 |
$698K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,846 |
6,554 |
$517K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,338 |
3,332 |
$243K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,212 |
3,194 |
$232K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,180 |
10,075 |
$217K |
| 92567 |
|
20,041 |
19,001 |
$216K |
| 92081 |
|
7,204 |
7,184 |
$189K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,270 |
2,270 |
$183K |
| 92552 |
|
9,275 |
8,975 |
$156K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,249 |
2,233 |
$148K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,673 |
7,633 |
$44K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,464 |
1,435 |
$35K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,999 |
2,885 |
$32K |
| 81000 |
|
7,577 |
7,399 |
$23K |
| 83655 |
|
2,356 |
2,335 |
$23K |
| 90671 |
|
361 |
360 |
$21K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,261 |
2,250 |
$21K |
| 69210 |
|
626 |
602 |
$18K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
335 |
330 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
10,565 |
10,475 |
$13K |
| 90697 |
|
148 |
148 |
$13K |
| 96127 |
|
3,165 |
3,151 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,366 |
2,321 |
$12K |
| 87070 |
|
1,710 |
1,676 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
620 |
618 |
$9K |
| 87110 |
|
918 |
915 |
$7K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
375 |
373 |
$6K |
| 90658 |
|
2,042 |
2,025 |
$5K |
| 86580 |
|
711 |
697 |
$3K |
| 81002 |
|
1,602 |
1,566 |
$3K |
| 90620 |
|
226 |
226 |
$3K |
| 90651 |
|
323 |
323 |
$3K |
| 99381 |
|
41 |
41 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
28 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
187 |
185 |
$2K |
| 90655 |
|
221 |
221 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
326 |
323 |
$2K |
| 99382 |
|
12 |
12 |
$1K |
| 36410 |
|
250 |
247 |
$1K |
| 90734 |
|
377 |
377 |
$675.89 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$500.06 |
| 81007 |
|
70 |
67 |
$247.36 |
| 90715 |
|
219 |
219 |
$232.50 |
| 90680 |
|
892 |
889 |
$109.25 |
| 87634 |
|
12 |
12 |
$81.37 |
| 90633 |
|
860 |
859 |
$79.18 |
| 90670 |
|
1,294 |
1,286 |
$50.07 |
| 90686 |
|
76 |
76 |
$23.53 |
| 86001 |
|
51 |
51 |
$20.32 |
| 90648 |
|
134 |
133 |
$15.22 |
| 36416 |
|
886 |
884 |
$3.18 |
| 90716 |
|
31 |
31 |
$0.00 |
| 90698 |
|
333 |
333 |
$0.00 |
| 90744 |
|
115 |
115 |
$0.00 |
| 90696 |
|
13 |
13 |
$0.00 |
| 90649 |
|
394 |
389 |
$0.00 |
| 3725F |
|
578 |
574 |
$0.00 |
| 90710 |
|
252 |
252 |
$0.00 |
| 90707 |
|
43 |
43 |
$0.00 |